Stockreport

Mid-stage study underway for Aclaris' ATI-502 for inherited hair loss [Seeking Alpha]

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
PDF Mid-stage study underway for Aclaris' ATI-502 for inherited hair lossThe first patient has beendosed in an open-labelPhase 2 clinical trial assessing Aclaris Therapeutic [Read more]